Skip to main content
Have a personal or library account? Click to login
Characteristics and Treatment of Hairy Cell Leukaemia Cover

Characteristics and Treatment of Hairy Cell Leukaemia

European Pharmaceutical Journal
Volume 61 (2014): Issue 1 (August 2014)
By:   
Open Access
|Aug 2014
References

References

  1. [1] Oleske, D. et al. A case-control inquiry into the etiology of hairy cell leukemia.1985; 121(5): 675-683.
    Open DOISearch in Google Scholar
  2. [2] Arons, E. et al. VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.2009; 114(21): 4687-4695.
    Open DOISearch in Google Scholar
  3. [3] Matutes, E. et al. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes., 1994; 14(1): 57-61.
    Search in Google Scholar
  4. [4] Falini, B. et al.: Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1).2004; 363(9424): 869-1871.
    Open DOISearch in Google Scholar
  5. [5] Tiacci, E. et al.: BRAF mutations in hairy-cell leukemia.2011; 364(24): 2305-2315.
    Open DOISearch in Google Scholar
  6. [6] Steis, R.G. et al. Serum solubile IL-2 receptor as a tumor marker in patients with hairy cell leukemia.1988; 71(5): 1304-1309.
    Open DOISearch in Google Scholar
  7. [7] Polliack, A. Hairy cell leukemia: biology, clinical diagnosis, unusual manifestations and associated disorders.2002; 6(4): 366-388.
    Open DOISearch in Google Scholar
  8. [8] Hisada, M., et al. Second cancer incidence and cause-specifc mortality among 3104 patients with hairy cell leukaemia: a population-based study.2007; 99(3): 215-222.
    Open DOISearch in Google Scholar
  9. [9] Seshadri, P. and Seshadri, R. Hairy cell leukemia: treatment prospects.2001; 1(1): 91-98.
    Open DOISearch in Google Scholar
  10. [10] Golde, D.W. Therapy of hairy-cell leukemia.1982; 307(8): 495-496.
    Open DOISearch in Google Scholar
  11. [11] Frassoldati, A. et al.: Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (IC-GHCL).1994; 13(3-4): 307-316.
    Open DOISearch in Google Scholar
  12. [12] Robak, T. et al. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.1999; 62(1): 49-56.
    Open DOISearch in Google Scholar
  13. [13] Greksák, R. et al. Treatment and prognosis of the patients with hairy cell leukemia, treated in the years 1996 – 2010 at the National Cancer Institute in Bratislava2011; 6(4): 241-245.
    Search in Google Scholar
  14. [14] Grever, M.R.: How I treat hairy cell leukemia.2010; 115(1): 21-28.
    Open DOISearch in Google Scholar
  15. [15] Greksák, R.: Establishment of the diagnosis and minimal residual disease in hairy cell leukaemia by fow cytom-etry of bone marrow aspirate and imunohistochemical examination of trepanobiopsy. In, 2012; 7(6): 406-409.
    Search in Google Scholar
  16. [16] Greksák, R. Hairy cell leukaemia – diagnostics, treatment and monoclonal antibodies, In, 2010; 16(3): 158-165.
    Search in Google Scholar
DOI: https://doi.org/10.2478/afpuc-2014-0002 | Journal eISSN: 2453-6725 (formerly 1338-6786) | Journal ISSN: 0301-2298
Journal RSS Feed
Language: English
Submitted on: Feb 14, 2014
Accepted on: Apr 2, 2014
Published on: Aug 30, 2014
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Keywords:
hairy cell leukaemia,
purine analogues,
interferon-α,
monoclonal antibodies,
survival
Related subjects:
Pharmacy,
Pharmacy, other

© 2014 R. Greksák, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 61 (2014): Issue 1 (August 2014)
Previous article
Next article